Banerjee Shyamashree, Sen Gupta Parth Sarthi, Bandyopadhyay Amal Kumar
Department of Biotechnology, The University of Burdwan, Burdwan, West Bengal, 713104, India.
BMC Immunol. 2017 Mar 6;18(1):13. doi: 10.1186/s12865-017-0197-9.
Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that causes Japanese Encephalitis (JE) and Acute Encephalitis Syndrome (AES) in humans. Genotype-I (as co-circulating cases with Genotype-III) was isolated in 2010 (JEV28, JEV21) and then in 2011 (JEV45) from Midnapur district, West Bengal (WB) for the first time from clinical patients who were previously been vaccinated with live attenuated SA14-14-2 strain. We apply bioinformatics and immunoinformatics on sequence and structure of E protein for analysis of crucial substitutions that might cause the genotypic transition, affecting protein-function and altering specificity of epitopes.
Although frequency of substitutions in E glycoprotein of JEV28, JEV21 and JEV45 isolates vary, its homologous patterns remain exactly similar as earlier Japan isolate (Ishikawa). Sequence and 3D model-structure based analyses of E protein show that only four of all substitutions are critical for genotype-I specific effect of which N103K is common among all isolates indicating its role in the transition of genotype-III to genotype-I. Predicted B-cell and T-cell epitopes are seen to harbor these critical substitutions that affect overall conformational stability of the protein. These epitopes were subjected to conservation analyses using a large set of the protein from Asian continent.
The study identifies crucial substitutions that contribute to the emergence of genotype-I. Predicted epitopes harboring these substitutions may alter specificity which might be the reason of reported failure of vaccine. Conservation analysis of these epitopes would be useful for design of genotype-I specific vaccine.
日本脑炎病毒(JEV)是一种由蚊子传播的黄病毒,可导致人类患日本脑炎(JE)和急性脑炎综合征(AES)。2010年(JEV28、JEV21)首次从西孟加拉邦(WB)米德纳布尔区临床患者中分离出基因型I(与基因型III共同流行的病例),这些患者此前接种过减毒活疫苗SA14 - 14 - 2株。我们应用生物信息学和免疫信息学对E蛋白的序列和结构进行分析,以确定可能导致基因型转变、影响蛋白质功能并改变表位特异性的关键替换。
尽管JEV28、JEV21和JEV45分离株E糖蛋白中的替换频率有所不同,但其同源模式与早期日本分离株(石川株)完全相似。基于E蛋白序列和三维模型结构的分析表明,所有替换中只有四个对基因型I的特异性效应至关重要,其中N103K在所有分离株中都有,表明其在基因型III向基因型I转变中的作用。预测的B细胞和T细胞表位含有这些影响蛋白质整体构象稳定性的关键替换。使用来自亚洲大陆的大量该蛋白对这些表位进行了保守性分析。
该研究确定了导致基因型I出现的关键替换。含有这些替换的预测表位可能会改变特异性,这可能是报道的疫苗失效的原因。对这些表位的保守性分析将有助于设计基因型I特异性疫苗。